FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Certificates

FDA
Registration Date 19 Jan 2015
Share

ABELCET®

(0)

Medicine Pharmaceuticals Product Number : 57665-101-41

Anti-fungal

Drug Information

Generic
amphotericin b lipid complex
NDC Code
57665-101-41
Drug Class
Polyene
Therapeutic Class
Antifungal
Dosage form
Solution
Route of Administration
Intravenous Injection
Therapeutic Area
1.Invasive fungal 2.Fungal infections

Nanomaterials

Liposome

Nanoliposome

Indication

"indicated for the treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy (Aspergillosis - Aspergilloma, Aspergillosis - Invasive, Blastomycosis, Candidemia, Coccidioidomycosis, Cryptococcosis, Histoplasmosis and Leishmaniasis)"

Benefit

The safety and tolerability profile of ABELCET has been well established over 10 years of clinical use. ABELCET is associated with significantly lower renal toxicity when compared to conventional amphotericin B